Fojann Intelligence (Shanghai) Pharmaceutical Co., Ltd

语言/Language

Fojann Intelligent microbial application platform integrates the functions of "cross-platform knowledge query and natural language question and answer", "integrated data display and simple health information analysis", "prospective knowledge reasoning and rapid drug screening" and "precise disease risk prediction and intestinal bacteria matching". It will improve the knowledge query, learning and sorting efficiency of researchers in the microbiology field, pharmaceutical company R&D personnel and clinicians, provide "zero code" bioinformatics analysis and scientific research mapping, help prospective live biological drug screening and prediction, and achieve accurate disease risk prediction and donor matching based on intestinal bacteria detection.

Test items: 01

Bacterial marker: Assess disease risk, such as specific bacterial species associated with Crohn's disease and their abundance.; 02

Inflammatory index: Understanding the extent of intestinal inflammation by detecting metabolites or bacterial products associated with the inflammatory response.; 03

Intestinal flora structure: To analyze the composition and diversity of the overall intestinal flora and evaluate the status of intestinal microecological balance.

Health implications: 01

Early detection of IBD: Patients with IBD are identified in the early stages of the disease for timely intervention and treatment.; 02

Directed personalized therapy: According to the test results, individual treatment plan can be developed for patients to improve the treatment effect.; 03

Monitor disease progression: Regular testing can track disease progression and treatment outcomes in patients with IBD and adjust treatment strategies.

Q

Which populations and organizations does Fojann's Smart Microbiology Application Platform target?

A

Fojann's intelligent microbiology application platform is aimed at scientific research organizations such as schools, hospitals and pharmaceutical companies to help researchers and developers in the field of microbiology and drug discovery.
Q

What can Fojann's intelligent microbial application platform do?

A

Fojann's Intelligent Microbiology Application Platform integrates “cross-platform knowledge query and natural language Q&A”, “integrated data display and simple bio-credit analysis”, “forward-looking knowledge reasoning and rapid drug screening”, and “precise disease risk prediction and enterobacterial mapping”. The integration of “cross-platform knowledge query and natural language Q&A”, “integrated data display and simple bio-confidence analysis”, “forward-looking knowledge reasoning and rapid drug screening” and “precise disease risk prediction and enterobacterial mapping” will improve the efficiency of knowledge query, learning and organization for researchers, pharmaceutical R&D personnel and clinicians in the field of microbiology, and provide “zero-code” It will improve the efficiency of knowledge query, learning and organization of researchers and clinicians in the field of microbiology, provide “zero-code” bio-credit analysis and scientific research mapping, and help prospective biopharmaceutical screening and prediction in vivo, as well as realize precise disease risk prediction and donor mating based on the detection of enteric bacteria.